ICN Pharmaceuticals Inc. to test AIDS treatment

The Costa Mesa drug research company said Thursday that its ribavirin drug will be tested on 21 AIDS victims at New York Hospital. The drug is used in fighting the virus believed to cause acquired immune deficiency syndrome. The company said it also is awaiting U.S. Food and Drug Administration approval for use of ribavirin in treating respiratory syncytial virus, a disease affecting about 800,000 infants, children and elderly annually in the United States.